Published in

Wiley, Diabetes, Obesity and Metabolism, 5(21), p. 1136-1145, 2019

DOI: 10.1111/dom.13627

Links

Tools

Export citation

Search in Google Scholar

Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study

Journal article published in 2019 by Anna Norhammar ORCID, Johan Bodegård ORCID, Thomas Nyström ORCID, Marcus Thuresson ORCID, David Nathanson ORCID, Jan W. Eriksson ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO